High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8857946

Download in:

View as

General Info

PMID
8857946